|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/192 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61P 17/04 | (2006.01) | ||
| A61P 1/16 | (2006.01) |
| (11) | Number of the document | 3973959 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21201888.1 |
| Date of filing the European patent application | 2018-09-24 | |
| (97) | Date of publication of the European application | 2022-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-11 |
| (46) | Date of publication of the claims translation | 2025-01-10 |
| (30) | Number | Date | Country code |
| 201762563395 P | 2017-09-26 | US |
| (72) |
BOUDES, Pol , US
MCWHERTER, Charles A. , US
STEINBERG, Alexandra S. , US
|
| (73) |
CymaBay Therapeutics, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Cholestazinio niežulio gydymas seladelparu |
| TREATMENT OF CHOLESTATIC PRURITUS WITH SELADELPAR |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 8 | 185.00 EUR |
| 2026-09-24 |